Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Optics Valley Vcanbio Cell & Gene Technology is a specialized biotechnology subsidiary of Vcanbio Cell & Gene Engineering Corp., Ltd., located in the Wuhan East Lake High-tech Development Zone (Optics Valley). The company focuses on the research, development, and clinical application of cell-based therapies, particularly mesenchymal stem cells (MSCs). Its core business includes the storage of umbilical cord and cord blood cells, as well as the development of therapeutic products for indications such as liver cirrhosis and autoimmune disorders. As a key regional hub for the parent company, it integrates cell resource banking with advanced regenerative medicine R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Optics Valley Vcanbio Cell & Gene Technology.